Publications by authors named "Nicolas Demogeot"

Claim this Profile
O
Oncological Outcomes and Organ Preservation After Brachytherapy for Penile Carcinoma: A Multicentric Retrospective Study by the Brachytherapy Group of the French Society for Radiation Oncology.
Kanta Ka, Abel Cordoba, Renaud Schiappa, Nicolas Martz, Sophie Espenel, Nicolas Demogeot

Int J Radiat Oncol Biol Phys· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial.
Nicolas Demogeot, Paul Sargos, Julia Salleron, Stéphane Guérif, Renaud de Crevoisier

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Federico Iori, Emanuele Alì, and Cinzia Iotti's Letter to the Editor re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019.
Nicolas Demogeot, Stéphane Supiot, Paul Sargos

Eur Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Mattia Longoni, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019.
Nicolas Demogeot, Stéphane Supiot, Paul Sargos

Eur Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local control and recurrence patterns after stereotactic irradiation delivered in more than 4 fractions for hepatocellular carcinomas and liver metastases: a retrospective study.
Alizée Renan, Marie Bruand, Maria Jolnerovski, Aboubacar Diallo, Nicolas Demogeot

Radiat Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern of recurrence after fractionated stereotactic reirradiation in adult glioblastoma.
Agathe Margulies, Nassim Sahki, Fabien Rech, Guillaume Vogin, Marie Blonski, Nicolas Demogeot

Radiat Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.
Céline Meyer, Sandrine Huger, Marie Bruand, Thomas Leroy, Jérémy Palisson, Nicolas Demogeot

Radiat Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.
Céline Meyer, Sandrine Huger, Marie Bruand, Thomas Leroy, Jérémy Palisson, Nicolas Demogeot

Radiat Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brachytherapy for favorable prognostic prostate cancer in men up to 60 years of age: Long term follow-up.
Juliette Jacques, Nassim Sahki, Émilie Meknaci, Pascal Eschwege, Didier Peiffert, Nicolas Demogeot

Brachytherapy· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant pulse-dose-rate brachytherapy for oral cavity and oropharynx carcinoma: Outcome and toxicity assessment of 66 patients.
Sophie Renard, Nicolas Demogeot, Marie Bruand, Nassim Sahki, Vincent Marchesi

J Contemp Brachytherapy· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group.
Kanta Ka, Renaud Schiappa, Mario Terlizzi, Frederic Mallet, Etienne Martin, Nicolas Demogeot

Radiother Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of fractionated stereotactic radiotherapy on activity of daily living and performance status in progressive/recurrent glioblastoma: a retrospective study.
Nicolas Demogeot, J Salleron, F Rech, L Taillandier, P Royer

Radiat Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis